Potential Utility of Laser Speckle Contrast Imaging to Detect Early Microcirculatory Changes Associated With Erythema Nodosum in Crohn's Disease: A Case Report
- PMID: 39607856
- PMCID: PMC12069988
- DOI: 10.1093/ibd/izae284
Potential Utility of Laser Speckle Contrast Imaging to Detect Early Microcirculatory Changes Associated With Erythema Nodosum in Crohn's Disease: A Case Report
Keywords: Crohn’s disease; cutaneous blood perfusion; erythema nodosum; inflammatory bowel disease; laser speckle contrast imaging.
Plain language summary
In this case report of a young female patient with Crohn’s disease, presenting with erythema nodosum, laser speckle contrast imaging was able to detect blood flow changes in the affected skin area before clinical signs of the skin lesion emerged.
Conflict of interest statement
None declared.
Similar articles
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Natalizumab for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006097. doi: 10.1002/14651858.CD006097. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. doi: 10.1002/14651858.CD006097.pub2. PMID: 16856112 Updated.
-
Natalizumab for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD006097. doi: 10.1002/14651858.CD006097.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2018 Aug 01;8:CD006097. doi: 10.1002/14651858.CD006097.pub3. PMID: 17253580 Updated.
-
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025. J Inflamm Res. 2025. PMID: 40535353 Free PMC article.
-
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
References
-
- Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M.. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20(1):213-227. doi: https://doi.org/10.1097/01.MIB.0000436959.62286.f9 - DOI - PubMed
-
- He R, Zhao S, Cui M, et al.Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. Front Immunol. 2023;14:1234535. doi: https://doi.org/10.3389/fimmu.2023.1234535 - DOI - PMC - PubMed
-
- Linkous C, Pagan AD, Shope C, et al.Applications of laser speckle contrast imaging technology in dermatology. JID Innov. 2023;3(5):100187. doi: https://doi.org/10.1016/j.xjidi.2023.100187 - DOI - PMC - PubMed
-
- Schaap MJ, Chizari A, Knop T, et al.Perfusion measured by laser speckle contrast imaging as a predictor for expansion of psoriasis lesions. Skin Res Technol. 2022;28(1):104-110. doi: https://doi.org/10.1111/srt.13098 - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources